Corcept Therapeutics (CORT) Tops Q4 EPS by 3c; Issues Light FY16 Revenue Outlook
Go back to Corcept Therapeutics (CORT) Tops Q4 EPS by 3c; Issues Light FY16 Revenue Outlook| Corcept Therapeutics, Inc. (NASDAQ: CORT) | Delayed: 111.66 +1.15 (1.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $110.51 | 52 Week High | $10.00 | |||
| Open | $110.61 | 52 Week Low | $3.22 | |||
| Day High | $114.09 | P/E | N/A | |||
| Day Low | $110.09 | EPS | $-0.46 | |||
| Volume | 183,337 | |||||
